Optima Medical Innovations Corp.

Total Valuation

Optima Medical Innovations Corp. carries a market capitalization of 101.43M, placing it among publicly traded companies globally. Its enterprise value stands at 15.13M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

Optima Medical Innovations Corp. currently has 50.65M shares outstanding.

Valuation Ratios

The price-to-sales ratio is 7.12, and the price-to-book ratio stands at -3.35.

Enterprise Valuation

On an enterprise value basis, Optima Medical Innovations Corp. trades at an EV/EBITDA multiple of 17.99 and an EV/FCF ratio of 16.19. The EV/Sales ratio of 7.79 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 64.82 provides insight into valuation relative to core operating earnings.

Financial Position

Optima Medical Innovations Corp. maintains a current ratio of 0.06, meaning it holds 0.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 41.18, indicating elevated leverage, while an interest coverage ratio of 1.16 demonstrates limited ability to service its debt obligations.

Financial Efficiency

Stock Price Statistics

Optima Medical Innovations Corp.'s stock has gained approximately 5600.00017% over the past 52 weeks. The 50-day moving average sits at 0.00, while the 200-day moving average is 0.00.

Income Statement

Over the trailing twelve months, Optima Medical Innovations Corp. generated 1.94M in revenue and converted that into -365,340.00 in net income, yielding earnings per share of 0.00. EBITDA reached 840,677.00, while operating income came in at 233,341.00.

Balance Sheet

Optima Medical Innovations Corp. holds 113.00 in cash and equivalents against 1.30M in total debt, resulting in a net debt position of 398,422.00. Total book value stands at -4.13M, with working capital of -2.41M providing operational flexibility.

Cash Flow

Optima Medical Innovations Corp. produced 212,259.00 in operating cash flow over the past twelve months. After subtracting -51.00 in capital expenditures, free cash flow totaled 212,208.00 - equivalent to 0.00 per share.

Margins

Optima Medical Innovations Corp. operates with a gross margin of 20.19, reflecting its pricing power and cost economics. The operating margin of 12.02 and net profit margin of -18.81 provide insight into operational efficiency.

Dividends & Yields

Stock Splits

Optima Medical Innovations Corp.'s most recent stock split took place on November 18, 2021 with a 5:1 split ratio.

Scores

Optima Medical Innovations Corp. posts an Altman Z-Score of -77.35, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.